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tTATE-OF-THE-ART PAPER1993Management of Patients After an ICD Shockoseph D. Mishkin, Sherry J. Saxonhouse, Gregory W. Woo, Thomas A. Burkart, William M. Miles,
amie B. Conti, Richard S. Schofield, Samuel F. Sears, Juan M. Aranda, Jr
n estimated 20% to 35% of heart failure (HF) patients who receive an implantable
ardioverter-defibrillator (ICD) for primary prevention will experience an appropriate shock
ithin 1 to 3 years, and 33% will experience an inappropriate shock. An ICD shock is
ssociated with a 2- to 5-fold increase in mortality, with the most common cause being
rogressive HF. This review by Mishkin and colleagues describes an evidence-based,
ultidisciplinary strategy for evaluating and managing HF patients who receive an ICD
hock. Interventions addressed include pharmacologic and device-based strategies such as
dding amiodarone, titrating HF medications, adjusting ICD sensitivity, and employing
ntitachycardia pacing.IEWPOINT2001The Early ICD Paradoxeffrey J. Goldberger, Rod Passman
he risk of sudden cardiac death (SCD) is highest early after a myocardial infarction and
rogressively declines over time; however, early implantable cardioverter-defibrillator (ICD)
lacement has failed to improve outcomes in several clinical trials. Goldberger and Passman
xplore this acute myocardial infarction (MI)–sudden cardiac death paradox in a Viewpoint
aper. They offer 3 potential explanations: 1) these cases of SCD may not be due to
rrhythmias; 2) ejection fraction may not be an adequate risk stratifier in this population; and
) the act of device implantation and testing may be deleterious and thereby offset any
otential benefits. Further investigation is needed to delineate the actual causes of death in
he early post-MI period and to determine which interventions would be of benefit.(continued on page A-24)
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ELINICAL RESEARCH2006Different Risk Factors for Sudden Cardiac Arrest in Men and Womenumeet S. Chugh, Audrey Uy-Evanado, Carmen Teodorescu, Kyndaron Reinier, Ronald Mariani,
aren Gunson, Jonathan Jui
hugh and colleagues noted that there are significant sex-based differences in the prevalence
f sudden cardiac arrest (SCA) and used the Ore-SUDS (Oregon Sudden Unexpected Death
tudy) to explore if the risk factors for SCA in men and women are the same. All cases
eeting criteria for SCA in the Portland, Oregon, metropolitan area were ascertained using
ultiple sources, and medical records were reviewed. Over 1,500 adult SCA cases were
dentified (women 36% vs. men 64%). Women were older and were significantly less likely to
ave severe left ventricular dysfunction or previously recognized coronary artery disease. These
ndings indicate that fewer women with SCA would have been eligible for prophylactic
mplantable cardioverter-defibrillator placement, which suggests the need for other methods
f SCA risk stratification.LINICAL RESEARCH2012Improved Transtelephonic Pacemaker Interrogation May Improve Outcomeseorge H. Crossley, Jane Chen, Wassim Choucair, Todd J. Cohen, Douglas C. Gohn, W. Ben Johnson,
leanor E. Kennedy, Luc R. Mongeon, Gerald A. Serwer, Hongyan Qiao, Bruce L. Wilkoff,
or the PREFER Study Investigators
urrently, pacemakers are fully interrogated in person at 6- to 12-month intervals, and some
odels transmit telephonically limited information, such as a current rhythm strip, more
requently. Crossley and colleagues compared this standard of care with newer remote
onitoring technology that enables full device interrogation including reviewing stored
lectrograms. The primary end point was the time to first diagnosis of a clinically actionable
vent, and this occurred earlier in the Remote arm (6 months) than in the Control arm (8
onths). Two percent of the events in the Control arm and 66% of the events in the Remote
rm were identified remotely. The ability to review stored events when pacemakers are
nterrogated remotely can lead to earlier diagnoses of status changes, such as paroxysmal atrial
brillation, that may require a change in treatment.
ditorial Comment: Mark H. Schoenfeld, p. 2020(continued on page A-29)
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ELINICAL RESEARCH2023Risk of Developing AF Is Not Affected by Antihypertensive Class. Julian Haywood, Charles E. Ford, Richard S. Crow, Barry R. Davis, Barry M. Massie,
aula T. Einhorn, Angela Williard, for the ALLHAT Collaborative Research Group
his subanalysis of the ALLHAT (Antihypertensive and Lipid-Lowering Treatment to
revent Heart Attack Trial) examined the incidence of new-onset atrial fibrillation or atrial
utter (AF/AFL) in subjects who were randomly assigned to amlodipine, lisinopril,
oxazosin, or chlorthalidone. New-onset AF/AFL, which occurred in 2.0% of patients, did
ot differ by antihypertensive treatment assignment or by assignment to pravastatin versus
sual care. There was a nearly 2.5-fold increase in mortality risk when AF/AFL was present
t baseline or developed during the trial. In this high-risk hypertensive population, pre-
xisting and new-onset AF/AFL were both associated with increased mortality, but these
esults do not offer guidance on medical interventions to reduce the risk of developing AF/
FL.LINICAL RESEARCH2032CHADS Score Predicts Risk of Left Atrial Appendage Thrombus2
arinya Puwanant, Brandon C. Varr, Kevin Shrestha, Sarah K. Hussain, W. H. Wilson Tang,
uvin S. Gabriel, Oussama M. Wazni, Mandeep Bhargava, Walid I. Saliba, James D. Thomas,
ruce D. Lindsay, Allan L. Klein
uwanant and colleagues sought to determine if patients with a low CHADS2 score require a
outine screening transesophageal echocardiogram (TEE) before pulmonary vein isolation
PVI). Pre-PVI TEEs from over 1,000 atrial fibrillation (AF) patients were reviewed. The
revalence of LA/LAA thrombus, sludge, and spontaneous echo contrast was 0.6%, 1.5%,
nd 35%, respectively. The prevalence of left atrial/left atrial appendage (LA/LAA) thrombus/
ludge increased with ascending CHADS2 score. No patient with a CHADS2 score of 0 had
A/LAA sludge/thrombus. The prevalence of LA/LAA sludge/thrombus in patients with
F undergoing a pre-PVI screening TEE is very low (2%) and increases significantly with
igher CHADS2 scores, suggesting that patients with CHADS2 of 0, who met the study
ntry criteria, may not require pre-PVI TEE.
ditorial Comment: Bradley P. Knight, p. 2040(continued on page A-30)
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ELINICAL RESEARCH2043Frequency of Atrial Arrhythmias After Heart or Lung Transplantsosé Dizon, Kimberly Chen, Matthew Bacchetta, Michael Argenziano, Donna Mancini, Angelo Biviano,
oshua Sonett, Hasan Garan
izon and colleagues compared the incidence of atrial arrhythmias after double-lung or heart
ransplant surgeries because both create a type of pulmonary vein isolation (PVI) caused by
he suture lines. In the heart transplant group, 4.6% had atrial fibrillation (AF) compared
ith 19% in the lung transplant group, which was similar to a group of control patients
ndergoing coronary artery bypass grafting. The heart transplant patients who developed AF
ere more likely to have myocardial dysfunction and graft rejection than those who did not.
hese findings suggest that cardiac autonomic denervation may have a protective effect
gainst atrial fibrillation in the post-operative setting, but that the PVI caused by the
triotomies during double-lung transplant procedures is not protective.ditorial Comment: Sanjay Dixit, p. 2049LINICAL RESEARCH2052Location of Mutations Affects Outcomes in Type 2 LQTSataru Shimizu, Arthur J. Moss, Arthur A. M. Wilde, Jeffrey A. Towbin, Michael J. Ackerman,
raig T. January, David J. Tester, Wojciech Zareba, Jennifer L. Robinson, Ming Qi, G. Michael Vincent,
lizabeth S. Kaufman, Nynke Hofman, Takashi Noda, Shiro Kamakura, Yoshihiro Miyamoto, Samit Shah,
init Amin, Ilan Goldenberg, Mark L. Andrews, Scott McNitt
himizu and colleagues reviewed the effect of the location, coding type, and topology of
CNH2(hERG) mutations on clinical phenotype in patients with type 2 long QT syndrome
LQTS). Over 800 subjects with 162 different mutations were studied. For patients with
issense mutations, the transmembrane pore and N-terminus regions were associated with
ncreased risk compared with the C-terminus region and the transmembrane nonpore region.
owever, for nonmissense mutations the location seemed less important. A significantly
igher risk was found in subjects with mutations located in -helical domains than in those
ith mutations in -sheet domains or other locations.
ditorial Comment: Koonlawee Nademanee, p. 2063(continued on page A-31)
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ELINICAL RESEARCH
2065New Strategy for Identifying Mutations Associated
With Catecholaminergic Polymorphic Ventricular Tachycardiargelia Medeiros-Domingo, Zahurul A. Bhuiyan, David J. Tester, Nynke Hofman, Hennie Bikker,
. Peter van Tintelen, Marcel M. A. M. Mannens, Arthur A. M. Wilde, Michael J. Ackerman
atecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) is believed to be
aused by gain of function mutations in the cardiac ryanodine receptor encoded by RYR2.
ost RYR2 mutational analyses to date have targeted 3 domains encoded by 40% of the
ranslated exons. Medeiros-Domingo and colleagues performed a mutational analysis of all
YR2 exons on patients with either a clinical diagnosis of CPVT or a high suspicion for this
isorder. Nearly one-half of subjects were found to have RYR2 mutations, and these mutations
ere found in 13 exons that are not typically analyzed. These results suggest that a
trategy of RYR2 screening that includes 16 exons would identify an RYR2 mutation in
wo-thirds of patients with CPVT1.LINICAL RESEARCH2075Ganglionated Plexi May Be the Link Between Sleep Apnea and AFuhammad Ghias, Benjamin J. Scherlag, Zhibing Lu, Guodong Niu, Annerie Moers, Warren M. Jackman,
alph Lazzara, Sunny S. Po
hias and colleagues designed an experimental model to simulate sleep apnea-induced atrial
brillation (AF) by temporarily halting respirations in anesthesized, intubated dogs.
bstructive apnea was induced by turning off the respirator during end expiration.
rogrammed pacing was then performed with S1-S2 5 to 10 ms earlier than the atrial
efractory period. Neural activity was monitored from the ganglionated plexi (GP) adjacent to
he right pulmonary veins. During apnea, this S1-S2 protocol induced AF in 9 of 10 dogs,
nd GP activity increased prior to AF onset. In a second series of studies, ablating the GP
revented the induction of AF. This experimental model of apnea links the risk of AF with
ctivity in the GP.
ditorial Comment: Samuel J. Asirvatham, Suraj Kapa, p. 2084(continued on page A-32)
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sYPERTENSION2087Earlier Reflection Wave Unlikely to Cause Aging Related Hypertensionrun J. Baksi, Thomas A. Treibel, Justin E. Davies, Nearchos Hadjiloizou, Rodney A. Foale, Kim H. Parker,
arrel P. Francis, Jamil Mayet, Alun D. Hughes
he arterial pressure waveform is divided into 2 components: an initial rise due to left
entricular ejection and a secondary rise caused by reflected waves. The rise in blood pressure
ith aging has been attributed to an increased magnitude and an earlier return of the
eflected waves. Baksi and colleagues performed a meta-analysis of studies have that examined
he relationship between these waves and aging. They report that in subjects of all ages,
eflection times were well within systole and there was only a small tendency for younger
ubjects to have later reflection. This difference amounted to only 0.7 ms per year; at this rate
f change, arrival of wave reflection during diastole would only occur at an age of 221 years.
hese findings challenge the current consensus view that a shift in timing of wave reflection
rom diastole to systole causes aging-related hypertension.CONGENITAL HEART DISEASE ONGENITAL HEART DISEASE2093Anemia Is Associated With Increased Mortality in ACHDonstantinos Dimopoulos, Gerhard-Paul Diller, Georgios Giannakoulas, Ricardo Petraco,
ikaterini Chamaidi, Evaggelia Karaoli, Michael Mullen, Lorna Swan, Massimo F. Piepoli,
hilip A. Poole-Wilson, Darrel P. Francis, Michael A. Gatzoulis
imopoulos and colleagues investigated the relationship between anemia and functional
apacity and mortality in adults with congenital heart disease (ACHD). Over 800 patients
ith ACHD, which was noncyanotic, had at least 1 measurement of hemoglobin; anemia
as defined as a hemoglobin concentration 13 g/dl in males and 12 g/dl in females. The
revalence of anemia was 13% and was highest in patients with congenitally-corrected
ransposition of the great arteries and Ebstein’s anomaly. Anemic patients had a 3-fold higher
ortality risk, which persisted after propensity score adjustment. These results suggest that
creening for anemia should be a part of the routine assessment of ACHD patients.
